MON-323 IGF-I Variability and Its Association with Demographic and Clinical Characteristics in Patients with Acromegaly Treated with Injectable Somatostatin Receptor Ligands (SRLS); Results from an International Prospective Phase III Study

Background: In clinical practice, most patients responding to injectable somatostatin receptor ligands exhibit IGF-I variability around the upper limit of normal (ULN) during long-term follow up. These fluctuations are thought to result from various factors such as assay variability, nutrition, como...

Descripción completa

Detalles Bibliográficos
Autores principales: Samson, Susan Leanne, Nachtigall, Lisa B, Fleseriu, Maria, Ur, Ehud, Ludlam, William Henry, Patou, Gary, Haviv, Asi, Gilgun-Sherki, Yossi, Biermasz, Nienke, Strasburger, Christian Joseph, Kennedy, Laurence, Melmed, Shlomo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Neuroendocrinology and Pituitary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7207788/
http://dx.doi.org/10.1210/jendso/bvaa046.1907

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7207788/
http://dx.doi.org/10.1210/jendso/bvaa046.1907

Ejemplares similares